We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-1 of 1

Ten steps global life sciences companies should take in 2011

  • Sidley Austin LLP
  • -
  • USA
  • -
  • February 16 2011

Focus on potential kickback, Foreign Corrupt Practices Act, and Good Clinical Practice liability, especially in developing countries